Status:
COMPLETED
31P Magnetic Resonance Spectroscopy Fructose Study
Lead Sponsor:
Stephen Bawden
Collaborating Sponsors:
Biotechnology and Biological Sciences Research Council
Unilever R&D
Conditions:
Healthy
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effects of an oral fructose challenge on liver adenosine triphosphate (ATP) reserves using 31P magnetic resonance spectroscopy (MRS) as a potential measur...
Detailed Description
This study uses 31P spectra acquired from the liver in healthy subjects following a fructose drink to monitor ATP levels. This is also related to baseline BMI, liver glycogen and liver lipid levels
Eligibility Criteria
Inclusion
- Male
- Age 18 - 30
- BMI 20 - 27 kg/m\^2
- Healthy
Exclusion
- Smokers
- Liver disease or Metabolic Disorders
- Metal implants (not suitable for MRI)
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02217605
Start Date
March 1 2011
End Date
December 1 2013
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nottingham
Nottingham, Nottinghamshire, United Kingdom, NG7 2RD